Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CovarsaDx supports clinical trials enabling FDA clearances and approvals (De Novo, 510(k), EUA), most recently providing regulatory and research expertise for Healgen's at-home COVID-19 + influenza test, which achieved FDA De Novo approval in 2024. CovarsaDx is an active, independent Clinical Research Organization (CRO) specializing in in vitro diagnostics (IVDs) and medical devices, providing clinical research, regulatory consulting, and quality assurance services to help diagnostics innovators bring products to market efficiently.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CovarsaDx.